103 related articles for article (PubMed ID: 9105257)
1. Prostate-specific antigen: characterization of epitopes by synthetic peptide mapping and inhibition studies.
Corey E; Wegner SK; Corey MJ; Vessella RL
Clin Chem; 1997 Apr; 43(4):575-84. PubMed ID: 9105257
[TBL] [Abstract][Full Text] [Related]
2. Anti-free prostate-specific antigen monoclonal antibody epitopes defined by mimotopes and molecular modeling.
Michel S; Deléage G; Charrier JP; Passagot J; Battail-Poirot N; Sibai G; Jolivet M; Jolivet-Reynaud C
Clin Chem; 1999 May; 45(5):638-50. PubMed ID: 10222350
[TBL] [Abstract][Full Text] [Related]
3. Analysis of prostate specific antigen and alpha1-antichymotrypsin interaction using antipeptide monoclonal antibodies.
Michel S; Charrier JP; Deleage G; Battail-Poirot N; Jolivet M; Jolivet-Reynaud C
J Urol; 2001 Jan; 165(1):301-6. PubMed ID: 11125429
[TBL] [Abstract][Full Text] [Related]
4. Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling.
Piironen T; Villoutreix BO; Becker C; Hollingsworth K; Vihinen M; Bridon D; Qiu X; Rapp J; Dowell B; Lövgren T; Pettersson K; Lilja H
Protein Sci; 1998 Feb; 7(2):259-69. PubMed ID: 9521101
[TBL] [Abstract][Full Text] [Related]
5. Epitope mapping of prostate-specific antigen with monoclonal antibodies.
Jette DC; Kreutz FT; Malcolm BA; Wishart DS; Noujaim AA; Suresh MR
Clin Chem; 1996 Dec; 42(12):1961-9. PubMed ID: 8969633
[TBL] [Abstract][Full Text] [Related]
6. Characterization of antibodies to prostate-specific antigen.
Nilsson O; Andersson I; Peter A; Karlsson B
Tumour Biol; 1999; 20 Suppl 1():43-51. PubMed ID: 10628409
[TBL] [Abstract][Full Text] [Related]
7. Epitope mapping of antibodies against prostate-specific antigen with use of peptide libraries.
Leinonen J; Wu P; Stenman UH
Clin Chem; 2002 Dec; 48(12):2208-16. PubMed ID: 12446478
[TBL] [Abstract][Full Text] [Related]
8. Characterization of epitope structure for 53 monoclonal antibodies against prostate-specific antigen.
Becker C; Wigheden I; Lilja H
Tumour Biol; 1999; 20 Suppl 1():13-7. PubMed ID: 10628403
[TBL] [Abstract][Full Text] [Related]
9. Characterization of novel monoclonal antibodies for prostate-specific antigen (PSA) with potency to recognize PSA bound to alpha 2-macroglobulin.
Baumgart Y; Otto A; Schäfer A; Usbeck E; Cott C; Schott A; Tornack M; Wenzel A; Mossie A; Birkenmeier G
Clin Chem; 2005 Jan; 51(1):84-92. PubMed ID: 15528296
[TBL] [Abstract][Full Text] [Related]
10. Epitope mapping and affinity estimation of 83 antibodies against prostate-specific antigen.
Paus E; Nustad K; Børmer OP
Tumour Biol; 1999; 20 Suppl 1():52-69. PubMed ID: 10628410
[TBL] [Abstract][Full Text] [Related]
11. Equivalent recognition of free and ACT-complexed PSA in a monoclonal-polyclonal sandwich assay is conferred by binding specificity of the monoclonal antibody.
Zhou Z; Armstrong EG; Belenky A; Freeman JV; Yeung KK
J Clin Lab Anal; 1998; 12(4):242-9. PubMed ID: 9671177
[TBL] [Abstract][Full Text] [Related]
12. Epitope mapping of 53 antibodies against prostate-specific antigen.
Bellanger L; Andrès C; Seguin P
Tumour Biol; 1999; 20 Suppl 1():18-23. PubMed ID: 10628404
[TBL] [Abstract][Full Text] [Related]
13. Immunological grouping of 53 antibodies against prostate-specific antigen.
Slota J; Lauren L; Rapp J; Dowell B
Tumour Biol; 1999; 20 Suppl 1():70-4. PubMed ID: 10628411
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the C-terminal end of the prostrate-specific antigen in a conformational epitope: characterization by proteolytic degradation of monoclonal antibody-bound antigen and mass spectrometry.
Michel S; Forest E; Pétillot Y; Deléage G; Heuzé-Vourc'h N; Courty Y; Lascoux D; Jolivet M; Jolivet-Reynaud C
J Mol Recognit; 2001; 14(6):406-13. PubMed ID: 11757074
[TBL] [Abstract][Full Text] [Related]
15. Characterization of 10 new monoclonal antibodies against prostate-specific antigen by analysis of affinity, specificity and function in sandwich assays.
Corey E; Wegner SK; Stray JE; Corey MJ; Arfman EW; Lange PH; Vessella RL
Int J Cancer; 1997 Jun; 71(6):1019-28. PubMed ID: 9185706
[TBL] [Abstract][Full Text] [Related]
16. Production and characterization of novel anti-prostate-specific antigen (PSA) monoclonal antibodies that do not detect internally cleaved Lys145-Lys146 inactive PSA.
Nurmikko P; Väisänen V; Piironen T; Lindgren S; Lilja H; Pettersson K
Clin Chem; 2000 Oct; 46(10):1610-8. PubMed ID: 11017939
[TBL] [Abstract][Full Text] [Related]
17. Three immunoassays based on monoclonal antibodies specific for prostate specific antigen (PSA), alpha-1-antichymotrypsin (ACT), and the PSA-ACT complex.
Wan XS; Xu YA; Ware JH; Kennedy AR
Prostate; 2003 Jul; 56(2):131-41. PubMed ID: 12746838
[TBL] [Abstract][Full Text] [Related]
18. Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex.
Pettersson K; Piironen T; Seppälä M; Liukkonen L; Christensson A; Matikainen MT; Suonpää M; Lövgren T; Lilja H
Clin Chem; 1995 Oct; 41(10):1480-8. PubMed ID: 7586521
[TBL] [Abstract][Full Text] [Related]
19. Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA.
Nilsson O; Peter A; Andersson I; Nilsson K; Grundström B; Karlsson B
Br J Cancer; 1997; 75(6):789-97. PubMed ID: 9062397
[TBL] [Abstract][Full Text] [Related]
20. Epitope analysis of a prostate-specific antigen (PSA) C-terminal-specific monoclonal antibody and new aspects for the discrepancy between equimolar and skewed PSA assays.
Nagasaki H; Watanabe M; Komatsu N; Kaneko T; Dubé JY; Kajita T; Saitoh Y; Ohta Y
Clin Chem; 1999 Apr; 45(4):486-96. PubMed ID: 10102908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
